<DOC>
	<DOCNO>NCT01780233</DOCNO>
	<brief_summary>The objective study compare rate absorption bioavailability fentanyl 400 µg sublingual spray , Actiq® 400 µg transmucosally , fentanyl citrate injection 100 µg intravenously .</brief_summary>
	<brief_title>Pharmacokinetic Study Fentanyl 400 µg Sublingual Spray , Actiq® 400 µg Transmucosally , Fentanyl Citrate Injection 100 µg Intravenously ( iv )</brief_title>
	<detailed_description>This Phase I , single-dose , open-label , randomize , 3-period , 3-treatment cross study 21 healthy subject receive single dos fentanyl 400 µg sublingual spray , Actiq® 400 µg transmucosally , fentanyl citrate injection 100 µg intravenously follow 10-hour overnight fast . There 7 day washout period treatment .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Male nonpregnant , nonbreastfeeding female age 1855 inclusive . Body Mass Index ( BMI ) 1830 kg/m^2 , inclusive , body weight least 60 kg ( 132 lb ) . Subject healthy accord medical history , laboratory result , physical examination . Had presence history clinically significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , oncologic , psychiatric disease condition , opinion Investigator would jeopardize safety subject validity study result . Had clinically significant abnormal find physical exam , medical history , electrocardiogram ( ECG ) , clinical laboratory result screen . Had significant history hypersensitivity opioid analgesic , fentanyl related product , naltrexone , severe hypersensitivity reaction ( like angioedema ) drug . Had significantly abnormal diet 4 week precede first dose study medication . Had donate blood plasma within 30 day prior first dose study medication course study . Had participate another clinical trial within 30 day prior first dose study medication course study . Had use overthecounter ( OTC ) medication , include nutritional supplement , within 7 day prior first dose study medication course study . Had use prescription medication , except hormonal contraceptive hormonal replacement therapy , within 14 day prior first dose study medication course study . Had use enzyme alter drug barbiturate , corticosteroid , phenothiazine , cimetidine , carbamazepine , etc , within 30 day prior first dose study medication course study . Had use opioid analgesic within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>